BIT

2.63%

2.0¢ biotron limited

$100+ billion deals?, page-45

First 45 Last

Share
Profile

Follow
Warnie

17,247 Posts.

955

06/02/20

17:25

Post #: 42786667
Share

Originally posted by elephantsong: ↑

I think a few people noticed the purchase by SL and RT.

I mean SL is an expert in Hepatits B.
A deal here would be in the vicintity of US 200-300+ alone.

RT....well he has deep pockets. He actually bought some more on market!

BIT is way undervalued....before the new coronavirus came along.

What people fail to realize is BIt is different mode of action from a lot of the new stuff.
It can be rapidly deployed.
They have a platform and a big library of compounds ... which have broad antiviral capabilities.Drugs capable of targeting viruses
in reservoir cells.

100 billion is higher end of the scale and probably too early ....but possible.
10 billion is very conservative.

If they can develop a new compound for the New CoronaVirus, within 1 month, it shows the true value of their platform.
Such Rapid development of compounds to target such pandemics is highly attractive.

National Security against Biothreats is becoming a priority for governments and others.

China could easily do a deal within a month with Biotron for US$500 million.
They could easily fastrack approval for New CoronaVirus.

A city of 10 million people in lockdown.

Biotron already have CoronaVirus expertise.

So what is the value of BIT225 and other compounds?
Hep C, Hep B, EBV, Zika, SARS, Flu, Dengue compounds?
They have over 400!

Whilst $100 billions seems high at this stage....$10 Billion is still looking conservative IMHO.

Note. BIT225 has undergone 12 years of testing. Extremely high safety profile.
And it restores immune response.

There will be a revaluation of BIT if the anti NewCoronaVirus compounds works.
Remember they have the virus isolated and in labs already. This is unprecedented.

Expand

Sounds great but you missed the part about BIT225 having zero FDA approval and no proof of eradicating coronavirus for that matter

Enjoy

BIT Price at posting: 10.0¢ Sentiment: Sell Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

First 45 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change 0.001(2.63%)		Mkt cap ! $17.59M

Open	High	Low	Value	Volume
1.9¢	2.0¢	1.9¢	$11.54K	604.2K

Buyers (Bids)

No.	Vol.	Price($)
10	1466986	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	830622	7

View Market Depth

No.	Vol.	Price($)
10	1466986	0.019
11	2301165	0.018
5	688000	0.017
11	1524350	0.016
4	660000	0.015

Price($)	Vol.	No.
0.020	830622	7
0.021	168000	2
0.022	600000	2
0.023	323000	3
0.024	255035	3

Last trade - 15.55pm 15/11/2024 (20 minute delay)

BIT (ASX) Chart

$100+ billion deals?, page-45

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

$100+ billion deals?, page-45

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News